Starting next season, the PGA Tour will implement significant changes to its anti-doping procedure. The Tour is adding blood testing and bringing its list of banned performance-enhancing substances in line with the World Anti-Doping Association, the Associated Press reports. The changes, which will take effect when the new season begins in October, will allow for the detection of Human Growth Hormone, which cannot be found through urine samples. However, the Tour plans to use urine samples for most of its testing. In addition, the Tour will publicly announce when golfers fail tests for PEDs as well as drugs of abuse. PED-related suspensions are not as common in golf as they are in other sports, but golfer Scott Stallings was suspended three months for violating the Tour’s anti-doping policy in 2015.